Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Interleukin-2 | 4 | 2017 | 1896 | 0.730 |
Why?
|
Melanoma, Experimental | 3 | 2016 | 558 | 0.630 |
Why?
|
Urologic Neoplasms | 1 | 2018 | 310 | 0.470 |
Why?
|
Interferon-alpha | 1 | 2016 | 910 | 0.400 |
Why?
|
Breast | 1 | 2021 | 1946 | 0.390 |
Why?
|
Biofilms | 1 | 2014 | 641 | 0.330 |
Why?
|
Arthritis | 1 | 2014 | 677 | 0.320 |
Why?
|
Prosthesis-Related Infections | 1 | 2014 | 496 | 0.320 |
Why?
|
Epitopes | 1 | 2015 | 2523 | 0.300 |
Why?
|
Bacterial Infections | 1 | 2014 | 1387 | 0.260 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3181 | 0.260 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3737 | 0.260 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4274 | 0.230 |
Why?
|
Bacteria | 1 | 2014 | 2209 | 0.220 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2021 | 116 | 0.170 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2023 | 790 | 0.140 |
Why?
|
Immunotherapy | 3 | 2017 | 4752 | 0.130 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2021 | 1441 | 0.130 |
Why?
|
Receptors, IgG | 2 | 2017 | 559 | 0.120 |
Why?
|
Adaptive Immunity | 2 | 2017 | 734 | 0.120 |
Why?
|
Tissue Distribution | 2 | 2017 | 2266 | 0.120 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2016 | 498 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21056 | 0.110 |
Why?
|
Antibodies, Neoplasm | 1 | 2015 | 282 | 0.110 |
Why?
|
DNA, Ribosomal | 1 | 2014 | 300 | 0.110 |
Why?
|
Phylogeny | 1 | 2021 | 2832 | 0.110 |
Why?
|
Biological Therapy | 1 | 2014 | 140 | 0.110 |
Why?
|
Ultrasonic Therapy | 1 | 2014 | 216 | 0.100 |
Why?
|
Hypersensitivity, Delayed | 1 | 2014 | 490 | 0.100 |
Why?
|
Models, Immunological | 1 | 2015 | 517 | 0.100 |
Why?
|
Integrins | 1 | 2017 | 840 | 0.100 |
Why?
|
Antibody Formation | 2 | 2017 | 1391 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2176 | 0.090 |
Why?
|
Germ-Free Life | 1 | 2011 | 187 | 0.090 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2014 | 1043 | 0.090 |
Why?
|
DNA, Bacterial | 1 | 2014 | 1477 | 0.080 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2014 | 618 | 0.080 |
Why?
|
Metals | 1 | 2014 | 710 | 0.080 |
Why?
|
Cancer Vaccines | 1 | 2016 | 1044 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10070 | 0.080 |
Why?
|
Dendritic Cells | 2 | 2017 | 2747 | 0.080 |
Why?
|
Electric Stimulation Therapy | 1 | 2014 | 635 | 0.080 |
Why?
|
Lymphocyte Activation | 2 | 2016 | 5501 | 0.080 |
Why?
|
Immunity, Mucosal | 1 | 2011 | 498 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4893 | 0.070 |
Why?
|
Hip Prosthesis | 1 | 2014 | 895 | 0.070 |
Why?
|
Immunity, Innate | 2 | 2016 | 3081 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2017 | 4642 | 0.060 |
Why?
|
Cytokines | 2 | 2022 | 7421 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 2531 | 0.060 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13648 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7478 | 0.060 |
Why?
|
Saccharomyces cerevisiae | 1 | 2015 | 2674 | 0.060 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2014 | 1416 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2021 | 22222 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 22331 | 0.050 |
Why?
|
Humans | 10 | 2023 | 765956 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18294 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3046 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 29921 | 0.040 |
Why?
|
Aged | 3 | 2021 | 171114 | 0.040 |
Why?
|
Proteins | 1 | 2015 | 5995 | 0.040 |
Why?
|
Lectins | 1 | 2022 | 487 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2011 | 4528 | 0.040 |
Why?
|
Female | 5 | 2021 | 396101 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10261 | 0.040 |
Why?
|
Middle Aged | 3 | 2021 | 223004 | 0.040 |
Why?
|
Animals | 5 | 2017 | 168759 | 0.040 |
Why?
|
Mice | 4 | 2017 | 81818 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2022 | 1183 | 0.030 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2016 | 105 | 0.030 |
Why?
|
Adiponectin | 1 | 2022 | 1119 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2016 | 5881 | 0.030 |
Why?
|
Cross Reactions | 1 | 2017 | 824 | 0.030 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2015 | 136 | 0.030 |
Why?
|
Risk Factors | 1 | 2021 | 74836 | 0.030 |
Why?
|
Leptin | 1 | 2022 | 1596 | 0.030 |
Why?
|
Serum Albumin | 1 | 2017 | 675 | 0.030 |
Why?
|
Male | 3 | 2021 | 363691 | 0.030 |
Why?
|
Patch Tests | 1 | 2014 | 57 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 798 | 0.030 |
Why?
|
Peptide Library | 1 | 2015 | 351 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1644 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2406 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13451 | 0.020 |
Why?
|
Bone Cements | 1 | 2014 | 318 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2022 | 3222 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2017 | 65189 | 0.020 |
Why?
|
Mutagenesis | 1 | 2015 | 1228 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4348 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 17075 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3850 | 0.020 |
Why?
|
Adult | 2 | 2021 | 223038 | 0.020 |
Why?
|
Ovalbumin | 1 | 2011 | 674 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2017 | 2324 | 0.020 |
Why?
|
Immunization | 1 | 2011 | 1219 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6309 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 13024 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2011 | 2669 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9373 | 0.020 |
Why?
|
Peptides | 1 | 2017 | 4331 | 0.020 |
Why?
|
Young Adult | 2 | 2022 | 59886 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3807 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4405 | 0.010 |
Why?
|
Reoperation | 1 | 2014 | 4294 | 0.010 |
Why?
|
Child | 2 | 2022 | 80563 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 88832 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16721 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9296 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5772 | 0.010 |
Why?
|
Patient Selection | 1 | 2014 | 4255 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7562 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26313 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13075 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42500 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10850 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 81515 | 0.010 |
Why?
|
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_